Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Folic acid is highly effective for prevention of neural tube defects (NTDs) when administered in the first trimester of pregnancy and the benefits are linearly related to plasma folate levels. Folic acid also lowers plasma homocysteine that has been linked with risk of stroke. However, the effects of different folic acid fortification types on NTD prevalence and stroke are uncertain. This presentation will review current folic acid fortification policies and their relevance for NTD and stroke prevention.

Robert Clarke is a Professor of Epidemiology and Public Health Medicine, Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford. 


This talk is open to members of the University only.

Forthcoming events

Correlates and consequences of atrial fibrillation in 25,000 CKB participants

Thursday, 28 September 2023, 12pm to 1pm @ BDI/OxPop Building LG seminar room 0

The epidemiology of periportal fibrosis in the context of intestinal schistosomiasis

Monday, 09 October 2023, 1pm to 2pm @ BDI/OxPop Building seminar rooms

Defeating Meningitis by 2023 Global Roadmap

Monday, 16 October 2023, 1pm to 2pm @ BDI/OxPop Building seminar room 1

OxPop Festival of Global Health - The Cancer Conflict

Thursday, 19 October 2023, 5pm to 8pm @ Richard Doll Lecture Theatre, Richard Doll Building, Roosevelt Drive, Oxford, OX3 7LF

Cancer Treatments: trust and information